Applying CRISPR‐Cas9 technology in a murine model, we found that Nf1 silencing in Kras‐mutant LUAD is associated with enhanced tumor cell viability, proliferation, endogenous tumor development, and xenograft tumor growth irrespective of p53 mutational status. Here, NF1 is linked to neoplasm.